Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Sep 5, 2023

Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments

Aug 10, 2023

Monopar Provides Encouraging Camsirubicin Clinical Data Update

Aug 8, 2023

Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore

Jul 11, 2023

Monopar to Participate in the Radiopharma Forum by the Lake 2023

Jun 21, 2023

Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference

Jun 14, 2023

Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update

Jun 1, 2023

Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments

May 11, 2023

Monopar to Present at the Jefferies Radiopharma Innovation Summit

Mar 28, 2023

Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis

Mar 27, 2023